Lv4
770 积分 2025-07-12 加入
Treatment of NSCLC after chemoimmunotherapy - are we making headway?
11个月前
已完结
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer
11个月前
已完结
Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1
1年前
已完结
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
1年前
已完结
The mutagenic forces shaping the genomes of lung cancer in never smokers
1年前
已完结
Tobacco Smoking and Risk for Pulmonary Fibrosis
1年前
已完结
皖公网安备34019202002308
